Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia.

Biological psychiatry - 15 Sept 1998

Hwu H G, Hong C J, Lee Y L, Lee P C, Lee S F

Abstract excerpt

BACKGROUND: Dopamine D4 receptor (DRD4) gene polymorphisms are associated with various pharmacologic activities. This study investigated whether polymorphisms of 48-bp tandem repeats in the exon 3 of the DRD4 gene are related to neuroleptic response. METHODS: The neuroleptic response at the acute stage of schizophrenia was assessed in 80 (48 men, 32 women) schizophrenic patients. The negative symptoms at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to DNA
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Receptors, Dopamine D2

Share to Repetitive Sequences, Nucleic Acid

Share to Schizophrenia

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 9777180
DOI: 10.1016/s0006-3223(98)00134-6

Genes

DRD4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia.PMID 9777180Read ↗

Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia.Semantic proximity Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.Semantic proximity Read ↗

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study.Semantic proximity Read ↗

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.Semantic proximity Read ↗

Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses.Semantic proximity Read ↗

Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophreniaSemantic proximity Read ↗

DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.Semantic proximity Read ↗

Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.Semantic proximity Read ↗

Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes.Semantic proximity Read ↗

Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls.Semantic proximity Read ↗

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.